EP3041828
Afleiður af 1,3,4-oxadíasól og 1,3,4-þíadíasól sem ónæmistemprandi lyf
:
EP Einkaleyfi fallið úr gildi:
5.9.2014:
23.5.2018:
14842822.0
:
20.8.2018:
15.9.2018
:
4.9.2034:
4.9.2019
:
1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE DERIVATIVES AS IMMUNOMODULATORS
5.9.2014
23.5.2018
20.8.2018
15.9.2018
4.9.2019
:
Aurigene Discovery Technologies Limited:
39-40 KIADB Industrial Area Electronic City Phase-II Hosur Road, 560100, Bangalore, Karnataka, IN
:
SASIKUMAR, Pottayil Govindan Nair:
Bangalore, IN
:
RAMACHANDRA, Muralidhara:
Bangalore, IN
:
NAREMADDEPALLI, Seetharamaiah Setty Sudarshan:
Bangalore, IN
:
Patice ehf.:
Pósthólf 8236, 128, Reykjavík,
:
4012CH2013:
6.9.2013:
IN
:
IB2014064281:
5.9.2014
:
C07D 271/06, C07D 285/08, A61K 31/4245, A61K 31/433, A61P 31/00, A61P 35/00
: 5
: 29.8.2018
: 4.9.2019
: PATICE, Ólafur Ragnarsson, hrl.